AI can identify patients at risk of dying—of any cause—within the next year or of developing an irregular heartbeat, according to two new studies to be presented at the American Heart Association’s Scientific Sessions 2019.
Gilead Sciences, a Foster City, California-based biopharmaceutical company, is scheduled to present new AI-powered research related to nonalcoholic steatohepatitis (NASH) at The Liver Meeting 2019 in Boston.
It is traditionally believed that men and women experience angina—the pain associated with coronary artery disease—in different ways, with men feeling it in their chest and women feeling it in their arms and back.
Cancer Research UK, one of the world’s largest charities focused on improving cancer treatments, has launched a new research network focused on advanced radiotherapy techniques, immunotherapies and AI.
CMS announced Thursday, Oct. 31, that 25 participants have advanced in the agency’s Artificial Intelligence Health Outcomes Challenge, putting them one step closer to earning $1 million in prize money.